ALIVUS

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Alivus Life Sciences Limited

Alivus Life Sciences Limited (ALIVUS), formerly Glenmark Life Sciences Limited (name changed December 2024), is a Mumbai, India-based Specialty & Generic Drug Manufacturer in the H...

हिन्दी में

Alivus Life Sciences Limited (ALIVUS), जिसका पूर्व नाम Glenmark Life Sciences Limited था (दिसंबर 2024 में नाम बदला गया), हेल्थकेयर सेक्टर में एक मुंबई, भारत-आधारित स्पेशलिटी और जेन...

₹1,326.3-0.82%1D
Previous trading day close · Data updates after market close
1W: -3.5%
1M: -5.3%
6M: +26.8%
1Y: +42.1%
71/100
GoodResearch Score
Market Cap
₹13.5K Cr
Mid Cap
P/E Ratio
25.17
Fair
P/B Ratio
5.04
Premium
ROE
18.9%
Strong
ROCE
25.7%
Excellent
Debt / Equity
0.02
Low debt
Div. Yield
0.4%
EV/EBITDA
16.49
Fair
52W Low: ₹819Current: ₹1,326.352W High: ₹1,493.8
At 75% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
82/100
Growth
Revenue, EPS, profit growth
60/100
Valuation
PE, PB, EV/EBITDA vs sector
57/100
Risk
Debt levels, volatility, coverage
98/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
25.17(Fair)
Forward P/E
22.44(Premium)
P/B Ratio
5.04(Premium)
P/S Ratio
5.44(Expensive)
EV/EBITDA
16.49(Expensive)
Dividend Yield
0.4%
5Y CAGR
N/A
Revenue Growth
7.9%(Moderate)
Profitability
ROE
18.9%(Good)
ROCE
25.7%(Excellent)
ROA
15.5%(Efficient)
Net Margin
21.6%(High)
EBITDA Margin
31.9%
Financial Health
Debt to Equity
0.02(Low debt)
Current Ratio
4.97(Healthy)
Quick Ratio
3.53(Good)
Interest Coverage
140.91x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
25(Oversold)
RSI Exp (14)
35(Neutral)
MACD
-1.520(Bearish)
MACD Signal
6.024
BB Position
0%(Lower band)
BB Width
6.77%(Normal)
ADX (14)
21.5(Weak trend)
Williams %R
-80.9(Oversold)
MFI (14)
32(Neutral)
CCI (20)
-191(Oversold)
Stoch %K
19(Oversold)
ATR (14)
44.89(Avg True Range)
OBV (M)
9.6(Positive)
1W OBV Chg
-2.3%(Decreasing)
Rel Volume
0.82x(Normal)
Volatility
36.3%(Moderate)
Max DD 1Y
-30.5%(Moderate)
EMA 200
1159.0
EMA 50
1332.7
SMA 200
1095.4
vs SMA 50
-2.5%(Below SMA50)
vs SMA 200
21.1%(Above SMA200)
Volume
1.32L
Avg Vol 3M
1.6L
Shareholding Pattern
Promoter
74.9%
High confidence
FII
5.3%
DII / MF
7.3%
Share ALIVUS
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.
Alivus Life Sciences Limited (ALIVUS) Share Price ₹1326.30 Today | StockSage Pro